Hepatopulmonary syndrome

Seminars in Respiratory and Critical Care Medicine

Volumn 33, Issue 1, 2012, Pages 11-16

  MacHicao, Victor I ^a   Fallon, Michaelb ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

contrast enhanced transthoracic echocardiography; hepatopulmonary syndrome; hypoxemia; liver transplantation; pulse oximetry

Indexed keywords

ALBUMIN TC 99M; ALMITRINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; INDOMETACIN; NITRIC OXIDE; NORFLOXACIN; PENTOXIFYLLINE; PHOSPHODIESTERASE INHIBITOR; RADIOISOTOPE; SOMATOSTATIN; TECHNETIUM 99M;

ARTICLE; BLOOD GAS ANALYSIS; CLINICAL FEATURE; CONTRAST ENHANCEMENT; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DISEASE SEVERITY; DYSPNEA; GARLIC; GASTROINTESTINAL TOXICITY; HEPATOPULMONARY SYNDROME; HEPATORENAL SYNDROME; HUMAN; HYPOXEMIA; INTRAPULMONARY VASCULAR DILATATION; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; LUNG BLOOD VESSEL; LUNG FUNCTION TEST; LUNG GAS EXCHANGE; LUNG SCINTISCANNING; MORTALITY; NONHUMAN; PALLIATIVE THERAPY; PLASMAPHERESIS; PORTAL HYPERTENSION; PRIORITY JOURNAL; PULSE OXIMETRY; SCORING SYSTEM; SCREENING TEST; SURVIVAL; THORAX RADIOGRAPHY; TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT; TRANSTHORACIC ECHOCARDIOGRAPHY; TREATMENT INDICATION; TREATMENT OUTCOME; VASODILATATION;

BLOOD GAS ANALYSIS; DRUG THERAPY; HEPATOPULMONARY SYNDROME; HUMANS; HYPERTENSION, PORTAL; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; LUNG;

EID: 84858727322     PISSN: 10693424     EISSN: 10989048     Source Type: Journal    
DOI: 10.1055/s-0032-1301730     Document Type: Article

References (36)

1. Rodrguez-Roisin R, Krowka MJ, Herv P, Fallon MB.; ERS Task Force Pulmonary-Hepatic Vascular Disorders (PHD) Scientific Committee. Pulmonary-hepatic vascular disorders (PHD). Eur Respir J: 2004; 24 5 861 880 (Pubitemid 39504442)
2. Martinez G, Barber JA, Navasa M, Roca J, Visa J, Rodriguez-Roisin R. Hepatopulmonary syndrome associated with cardiorespiratory disease. J Hepatol: 1999; 30 5 882 889 (Pubitemid 29248990)
3. Schraufnagel DE, Kay JM. Structural and pathologic changes in the lung vasculature in chronic liver disease. Clin Chest Med: 1996; 17 1 1 15 (Pubitemid 26100790)
4. Degano B, Mittaine M, Herv P., et al. Nitric oxide production by the alveolar compartment of the lungs in cirrhotic patients. Eur Respir J: 2009; 34 1 138 144
5. Delclaux C, Mahut B, Zerah-Lancner F., et al. Increased nitric oxide output from alveolar origin during liver cirrhosis versus bronchial source during asthma. Am J Respir Crit Care Med: 2002; 165 3 332 337 (Pubitemid 34118504)
6. Rolla G, Brussino L, Colagrande P., et al. Exhaled nitric oxide and impaired oxygenation in cirrhotic patients before and after liver transplantation. Ann Intern Med: 1998; 129 5 375 378 (Pubitemid 28402792)
7. Fallon MB, Abrams GA, Luo B, Hou Z, Dai J, Ku DD. The role of endothelial nitric oxide synthase in the pathogenesis of a rat model of hepatopulmonary syndrome. Gastroenterology: 1997; 113 2 606 614 (Pubitemid 27351790)
8. Ling Y, Zhang J, Luo B., et al. The role of endothelin-1 and the endothelin B receptor in the pathogenesis of hepatopulmonary syndrome in the rat. Hepatology: 2004; 39 6 1593 1602 (Pubitemid 38702660)
9. Carter EP, Hartsfield CL, Miyazono M, Jakkula M, Morris KG Jr, McMurtry IF. Regulation of heme oxygenase-1 by nitric oxide during hepatopulmonary syndrome. Am J Physiol Lung Cell Mol Physiol: 2002; 283 2 L346 L353 (Pubitemid 34803991)
10. Zhang J, Ling Y, Luo B., et al. Analysis of pulmonary heme oxygenase-1 and nitric oxide synthase alterations in experimental hepatopulmonary syndrome. Gastroenterology: 2003; 125 5 1441 1451 (Pubitemid 37409764)
11. Zhang J, Luo B, Tang L., et al. Pulmonary angiogenesis in a rat model of hepatopulmonary syndrome. Gastroenterology: 2009; 136 3 1070 1080
12. Fallon MB, Krowka MJ, Brown RS., et al. Pulmonary Vascular Complications of Liver Disease Study Group. Impact of hepatopulmonary syndrome on quality of life and survival in liver transplant candidates. Gastroenterology: 2008; 135 4 1168 1175
13. Martnez GP, Barber JA, Visa J., et al. Hepatopulmonary syndrome in candidates for liver transplantation. J Hepatol: 2001; 34 5 651 657 (Pubitemid 32488779)
14. Schenk P, Schöniger-Hekele M, Fuhrmann V, Madl C, Silberhumer G, Müller C. Prognostic significance of the hepatopulmonary syndrome in patients with cirrhosis. Gastroenterology: 2003; 125 4 1042 1052 (Pubitemid 37193451)
15. Swanson KL, Wiesner RH, Krowka MJ. Natural history of hepatopulmonary syndrome: impact of liver transplantation. Hepatology: 2005; 41 5 1122 1129 (Pubitemid 40593920)
16. Abrams GA, Jaffe CC, Hoffer PB, Binder HJ, Fallon MB. Diagnostic utility of contrast echocardiography and lung perfusion scan in patients with hepatopulmonary syndrome. Gastroenterology: 1995; 109 4 1283 1288
17. Tanikella R, Kochar R, Kawut SM, Machicao VI, Fallon MB. Intrapulmonary vasodilatation and survival in liver transplant candidates [abstract]. Hepatology: 2010; 52 S1 A1207
18. Palma DT, Philips GM, Arguedas MR, Harding SM, Fallon MB. Oxygen desaturation during sleep in hepatopulmonary syndrome. Hepatology: 2008; 47 4 1257 1263 (Pubitemid 351547912)
19. Wolfe JD, Tashkin DP, Holly FE, Brachman MB, Genovesi MG. Hypoxemia of cirrhosis: detection of abnormal small pulmonary vascular channels by a quantitative radionuclide method. Am J Med: 1977; 63 5 746 754 (Pubitemid 8222941)
20. Lima BL, Frana AV, Pazin-Filho A., et al. Frequency, clinical characteristics, and respiratory parameters of hepatopulmonary syndrome. Mayo Clin Proc: 2004; 79 1 42 48 (Pubitemid 38018583)
21. Abrams GA, Sanders MK, Fallon MB. Utility of pulse oximetry in the detection of arterial hypoxemia in liver transplant candidates. Liver Transpl: 2002; 8 4 391 396 (Pubitemid 34467375)
22. Arguedas MR, Singh H, Faulk DK, Fallon MB. Utility of pulse oximetry screening for hepatopulmonary syndrome. Clin Gastroenterol Hepatol: 2007; 5 6 749 754
23. Abrams GA, Nanda NC, Dubovsky EV, Krowka MJ, Fallon MB. Use of macroaggregated albumin lung perfusion scan to diagnose hepatopulmonary syndrome: a new approach. Gastroenterology: 1998; 114 2 305 310 (Pubitemid 28093537)
24. Roberts DN, Arguedas MR, Fallon MB. Cost-effectiveness of screening for hepatopulmonary syndrome in liver transplant candidates. Liver Transpl: 2007; 13 2 206 214 (Pubitemid 46351645)
25. Sztrymf B, Rabiller A, Nunes H., et al. Prevention of hepatopulmonary syndrome and hyperdynamic state by pentoxifylline in cirrhotic rats. Eur Respir J: 2004; 23 5 752 758 (Pubitemid 38618148)
26. Zhang J, Ling Y, Tang L., et al. Pentoxifylline attenuation of experimental hepatopulmonary syndrome. J Appl Physiol: 2007; 102 3 949 955 (Pubitemid 46377017)
27. Tanikella R, Philips GM, Faulk DK, Kawut SM, Fallon MB. Pilot study of pentoxifylline in hepatopulmonary syndrome. Liver Transpl: 2008; 14 8 1199 1203
28. Gupta LB, Kumar A, Jaiswal AK., et al. Pentoxifylline therapy for hepatopulmonary syndrome: a pilot study. Arch Intern Med: 2008; 168 16 1820 1823
29. Gupta S, Faughnan ME, Lilly L, Hutchison S, Fowler R, Bayoumi AM. Norfloxacin therapy for hepatopulmonary syndrome: a pilot randomized controlled trial. Clin Gastroenterol Hepatol: 2010; 8 12 1095 1098
30. Abrams GA, Fallon MB. Treatment of hepatopulmonary syndrome with Allium sativum L. (garlic): a pilot trial. J Clin Gastroenterol: 1998; 27 3 232 235 (Pubitemid 28495842)
31. Najafi Sani M, Kianifar HR, Kianee A, Khatami G. Effect of oral garlic on arterial oxygen pressure in children with hepatopulmonary syndrome. World J Gastroenterol: 2006; 12 15 2427 2431
32. De BK, Dutta D, Pal SK, Gangopadhyay S, Das Baksi S, Pani A. The role of garlic in hepatopulmonary syndrome: a randomized controlled trial. Can J Gastroenterol: 2010; 24 3 183 188
33. Krowka MJ, Mandell MS, Ramsay MA., et al. Hepatopulmonary syndrome and portopulmonary hypertension: a report of the multicenter liver transplant database. Liver Transpl: 2004; 10 2 174 182 (Pubitemid 38240114)
34. Arguedas MR, Abrams GA, Krowka MJ, Fallon MB. Prospective evaluation of outcomes and predictors of mortality in patients with hepatopulmonary syndrome undergoing liver transplantation. Hepatology: 2003; 37 1 192 197 (Pubitemid 36042160)
35. Gupta S, Castel H, Rao RV., et al. Improved survival after liver transplantation in patients with hepatopulmonary syndrome. Am J Transplant: 2010; 10 2 354 363
36. Sulieman BM, Hunsicker LG, Katz DA, Voigt MD. OPTN policy regarding prioritization of patients with hepatopulmonary syndrome: does it provide equitable organ allocation? Am J Transplant: 2008; 8 5 954 964 (Pubitemid 351537751)